COVID-19; SARS-CoV-2
Showing 26 - 50 of >10,000
SARS-CoV-2 Vaccination on Cancer Patients Infected With
Recruiting
- COVID-19 Infection
- COVID-19 Vaccine
- no intervention
-
Beijing, Beijing, ChinaSanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023
Long COVID Trial in München
Recruiting
- Long COVID
-
München, GermanyMünchen Klinik Schwabing
Dec 13, 2022
COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))
Recruiting
- COVID-19
- SARS-CoV-2 DNA Vaccine (ICCOV)
-
Wong Chuk Hang, Hong KongGleneagles Hospital Hong Kong
Jun 16, 2023
Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test
Not yet recruiting
- SARS-CoV-2
- +3 more
- LumiraDx SARS-CoV-2 & Flu A/B
-
Cullman, AlabamaCullman Clinical Trials
Mar 16, 2023
Sars-Covid-19 Vaccines in Haematological Patients: Prospective
Completed
- Hematologic Diseases
- IgG antibodies to Sars-Cov-2
- QuantiFERON SARS-CoV-2 test
-
Monza, Lombardia, ItalySan Gerardo Hospital
Jan 23, 2023
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive
Not yet recruiting
- COVID-19
- +5 more
- imPulse™ Una infrasound-to-ultrasound e-stethoscope
- (no location specified)
Mar 9, 2023
Truenat™MTB Plus/COVID-19 Test for TB and COVID-19
Not yet recruiting
- TB
- COVID-19
- Truenat™ MTB Plus/COVID-19
- (no location specified)
Jun 10, 2022
Vitamin A and E Deficiency With Severity of SARS-COV-2 Disease:
Completed
- COVID-19
-
Cairo, None Selected, Egyptbalsam Sherif Fahmy
Jul 12, 2023
Covid19, SARS-COV-2 Infection Trial (DWJ1248, Placebo)
Terminated
- Covid19
- SARS-COV-2 Infection
- DWJ1248
- Placebo
-
Seoul, Korea, Republic ofSamsung Medical Center
Dec 4, 2022
Long COVID, Post-Acute Sequela of COVID-19, Post-Acute COVID-19 Trial in San Francisco (AER002, Placebo)
Not yet recruiting
- Long COVID
- +2 more
- AER002
- Placebo
-
San Francisco, CaliforniaUCSF/Zuckerberg San Francisco General Hospital
Jun 2, 2023
Zinc Deficiency, Sars-CoV-2 Infection Trial in Barcelona (Zinc Acetate)
Completed
- Zinc Deficiency
- Sars-CoV-2 Infection
- Zinc Acetate
-
Barcelona, SpainHospital del Mar
Mar 18, 2023
A Study of the Effectiveness of Moderna COVID-19 Vaccine
Recruiting
- SARS-CoV-2
- COVID-19
- mRNA-1273
-
Pasadena, CaliforniaKaiser Permanente Southern California
Jul 5, 2023
COVID-19, SARS-CoV2 Trial in Copenhagen (High intensity interval training, Standard care)
Completed
- COVID-19, SARS-CoV2
- High intensity interval training
- Standard care
-
Copenhagen, DenmarkRigshospitalet
Jun 3, 2022
Description of Immunologic, Enzymatic and Metabolic Biomarkers
Recruiting
- Covid19
- Blood collection at Day 8, Day 16, Day 24, Month 6 and Month 12 after first symptoms from SARS-CoV-2 infection.
- Blood collection at 1st injection of vaccine against COVID-19, at at second injection of vaccine, at Month 1, Month 2, Month 6 and Month 12 after second injection of vaccine for volunteers
-
Poitiers, FranceC.H.U.de Poitiers
Jun 22, 2022
COVID-19, SARS-CoV-2 Trial in Seoul (QTP104 1ug, QTP104 5ug, QTP104 25ug)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- QTP104 1ug
- +2 more
-
Seoul, Korea, Republic of
- +1 more
May 24, 2023
COVID-19 (SARS-CoV-2 Infection) Trial in Genova (Sentinox--Group A, Sentinox--Group B)
Completed
- COVID-19 (SARS-CoV-2 Infection)
- Sentinox--Group A
- Sentinox--Group B
-
Genova, ItalyOspedale Policlinico San Martino IRCCS
Jul 25, 2022
SARS-CoV-2 Infection Trial in Shinagawa-ku (S-217622, Placebo)
Recruiting
- SARS-CoV-2 Infection
- S-217622
- Placebo
-
Shinagawa-ku, Higashioi, JapanTokyo Shinagawa Hospital Social Medical Corporation Association
Jun 13, 2023
Sars-CoV-2 Infection, COVID-19 Trial in Knoxville (Rapid SARS-CoV-2 Antigen Test)
Completed
- Sars-CoV-2 Infection
- COVID-19
- Rapid SARS-CoV-2 Antigen Test
-
Knoxville, TennesseeEDP Biotech Corporation
Oct 14, 2022
Sustained Immunity to COVID-19 as Measured by SARS-CoV-2
Recruiting
- Covid19
- Serologic immunoassays to SARS-CoV-2 antibodies
-
Detroit, MichiganHenry Ford Health System
Dec 13, 2022
COVID-19 SARS-CoV-2 Infection Trial (CoronaVac, SCTV01E)
Not yet recruiting
- COVID-19 SARS-CoV-2 Infection
- CoronaVac
- SCTV01E
- (no location specified)
Jan 4, 2023
Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus
Not yet recruiting
- COVID-19
- Diabete Mellitus
- Measure of physiologic parameters
-
San Antonio, TexasTexas Diabetes Institute - University Health System
May 17, 2023
SARS CoV 2 Infection, COVID-19 Trial in Brussels (Humoral immunity)
Enrolling by invitation
- SARS CoV 2 Infection
- COVID-19
- Humoral immunity
-
Brussels, BelgiumSciensano
Jan 16, 2023
SARS-CoV-2 Infection Among Healthcare Workers
Recruiting
- COVID-19
- inactivated COVID-19 vaccines; orally aerosolized Ad5-nCoV
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Jan 10, 2023
COVID19 Trial in San José (Breath sample)
Withdrawn
- COVID19
- Breath sample
-
San José, Costa RicaInstituto Costarricense de Investigaciones Clínicas
Nov 22, 2022
NIH RECOVER Tissue Pathology: Understanding Long-Term Impact of
Recruiting
- COVID-19
- SARS CoV 2 Infection
-
New York, New YorkNYU Langone Health
Jan 25, 2023